Adage Capital Partners
GRNA

Adage Capital Partners’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Adage Capital Partners’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-531,778
Closed -$5.26M – 1126
2021
Q3 		$5.26M Sell
531,778
-1,318,222
-71% -$12.9M 0.01% 827
2021
Q2 		$18.1M Hold
1,850,000
– – 0.04% 504
2021
Q1 		$17.9M Buy
+1,850,000
New +$18.2M 0.04% 497

Other funds holding GRNA

HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
KC
Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

Adage Capital Partners's GRNA Position: Q4 2021 in Review

Adage Capital Partners sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q4 2021, closing a stake of 531,778 shares — an estimated $5.26M sold.

Adage Capital Partners first reported a position in GRNA in Q1 2021 and held it in 3 quarters. The position peaked at $18.1M in Q2 2021. 68 funds tracked by Wall St. Rank hold GRNA as of Q4 2021.

  • Adage Capital Partners reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q4 2021 after selling out during the quarter.
  • Adage Capital Partners sold 531,778 GreenLight Biosciences Holdings, PBC Common Stock shares in Q4 2021, an estimated $5.26M.
  • Adage Capital Partners first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2021 and held it in 3 quarters.
  • Adage Capital Partners's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $18.1M in Q2 2021.
  • 68 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q4 2021.

Based on Adage Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.